Fluid ORiented Therapy for yoUNg Asa 1patients

Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03090399

Enrollment

Registered

2017-03-24

Start date

2012-01-31

Completion date

2017-01-31

Last updated

2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics

Keywords

Goal Directed Fluid Therapy

Brief summary

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

Interventions

DEVICEFloTrac

For patients belonging to case group a Pulse Contour Analysis was adopted for optimize fluid administration

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* ASA 1

Exclusion criteria

* cardiac diseases * pulmonary diseases * renal diseases * metabolic disorders

Design outcomes

Primary

Measure	Time frame
prevalence of complications	up to 30 days

Secondary

Measure	Time frame
days of hospitalization	up to 12 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026